The role of pharmacogenetics in personalizing anticoagulant therapy: data from the Astrakhan region
The metabolic characteristics of anticoagulants largely depend on the patient’s genetic profile, determining the variability of pharmacological response to drugs and the risk of adverse reactions. Among the key genes encoding enzymes responsible for anticoagulant metabolism are CES1, CYP2C9, and VKO...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute
2026-07-01
|
| Seri Bilgileri: | Фармация и фармакология (Пятигорск) |
| Konular: | |
| Online Erişim: | https://www.pharmpharm.ru/jour/article/view/1927 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|